Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.

Warren RB, Marsden A, Tomenson B, Mason KJ, Soliman MM, Burden AD, Reynolds NJ, Stocken D, Emsley R, Griffiths CEM, Smith C; PSORT Consortium and on behalf of the BADBIR Study Group.

Br J Dermatol. 2018 Aug 28. doi: 10.1111/bjd.16776. [Epub ahead of print]

PMID:
30155885
2.

Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain.

Mason KJ, O'Neill TW, Lunt M, Jones AKP, McBeth J.

Scand J Pain. 2018 Jan 26;18(1):59-69. doi: 10.1515/sjpain-2017-0109.

PMID:
29794289
3.

Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.

Garcia-Doval I, Descalzo MA, Mason KJ, Cohen AD, Ormerod AD, Gómez-García FJ, Cazzaniga S, Feldhamer I, Ali H, Herrera-Acosta E, Griffiths CEM, Stern RS, Naldi L; Psonet Network.

Br J Dermatol. 2018 Oct;179(4):863-871. doi: 10.1111/bjd.16715. Epub 2018 Jul 24.

PMID:
29723914
4.

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.

Mason KJ, Barker JNWN, Smith CH, Hampton PJ, Lunt M, McElhone K, Warren RB, Yiu ZZN, Griffiths CEM, Burden AD; BADBIR Study Group.

JAMA Dermatol. 2018 May 1;154(5):581-588. doi: 10.1001/jamadermatol.2018.0183.

PMID:
29590279
5.

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Iskandar IYK, Warren RB, Lunt M, Mason KJ, Evans I, McElhone K, Smith CH, Reynolds NJ, Ashcroft DM, Griffiths CEM; BADBIR Study Group.

J Invest Dermatol. 2018 Apr;138(4):775-784. doi: 10.1016/j.jid.2017.09.044. Epub 2017 Dec 6.

6.

Risk of cancer in patients with psoriasis on biological therapies: a systematic review.

Peleva E, Exton LS, Kelley K, Kleyn CE, Mason KJ, Smith CH.

Br J Dermatol. 2018 Jan;178(1):103-113. doi: 10.1111/bjd.15830. Epub 2017 Dec 18. Review.

PMID:
28722163
7.

Identification of factors that may influence the selection of first-line biological therapy for people with psoriasis: a prospective, multicentre cohort study.

Davison NJ, Warren RB, Mason KJ, McElhone K, Kirby B, Burden AD, Smith CH, Payne K, Griffiths CEM.

Br J Dermatol. 2017 Sep;177(3):828-836. doi: 10.1111/bjd.15551. Epub 2017 Jul 26.

PMID:
28386916
8.

POGZ truncating alleles cause syndromic intellectual disability.

White J, Beck CR, Harel T, Posey JE, Jhangiani SN, Tang S, Farwell KD, Powis Z, Mendelsohn NJ, Baker JA, Pollack L, Mason KJ, Wierenga KJ, Arrington DK, Hall M, Psychogios A, Fairbrother L, Walkiewicz M, Person RE, Niu Z, Zhang J, Rosenfeld JA, Muzny DM, Eng C, Beaudet AL, Lupski JR, Boerwinkle E, Gibbs RA, Yang Y, Xia F, Sutton VR.

Genome Med. 2016 Jan 6;8(1):3. doi: 10.1186/s13073-015-0253-0.

9.

The role of adjunctive exenatide therapy in pediatric type 1 diabetes.

Raman VS, Mason KJ, Rodriguez LM, Hassan K, Yu X, Bomgaars L, Heptulla RA.

Diabetes Care. 2010 Jun;33(6):1294-6. doi: 10.2337/dc09-1959. Epub 2010 Mar 23.

10.

Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia.

Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW.

J Clin Endocrinol Metab. 2009 May;94(5):1608-11. doi: 10.1210/jc.2008-2580. Epub 2009 Feb 3.

11.

Targeting blood glucose management in school improves glycemic control in children with poorly controlled type 1 diabetes mellitus.

Nguyen TM, Mason KJ, Sanders CG, Yazdani P, Heptulla RA.

J Pediatr. 2008 Oct;153(4):575-8. doi: 10.1016/j.jpeds.2008.04.066.

PMID:
18847622
12.

Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes.

Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW.

Pediatr Diabetes. 2008 Dec;9(6):561-6. doi: 10.1111/j.1399-5448.2008.00430.x. Epub 2008 Aug 27.

PMID:
18761650
13.

The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes.

Rodriguez LM, Mason KJ, Haymond MW, Heptulla RA.

Pediatr Res. 2007 Dec;62(6):746-9.

PMID:
17957149
14.

Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus.

Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA.

Pediatr Diabetes. 2007 Aug;8(4):214-9.

PMID:
17659063
15.

Neuromuscular scoliosis: a case of the pediatric patient in the adult ICU.

Mason KJ.

Crit Care Nurs Q. 1998 Aug;21(2):64-80. Review.

PMID:
9739230
16.

Congenital orthopedic anomalies and their impact on the family.

Mason KJ.

Nurs Clin North Am. 1991 Mar;26(1):1-16. Review.

PMID:
2000311
17.

Pediatric orthopaedics: developmental norms.

Mason KJ.

Orthop Nurs. 1989 Jul-Aug;8(4):45-50. Review.

PMID:
2668860
18.

Reproductive tract infections in a family planning population in rural Bangladesh.

Wasserheit JN, Harris JR, Chakraborty J, Kay BA, Mason KJ.

Stud Fam Plann. 1989 Mar-Apr;20(2):69-80.

PMID:
2785722
19.

Ectopic pregnancy and prior induced abortion.

Burkman RT, Mason KJ, Gold EB.

Contraception. 1988 Jan;37(1):21-7.

PMID:
3365981

Supplemental Content

Loading ...
Support Center